Yu Deng

2.2k total citations · 1 hit paper
38 papers, 1.5k citations indexed

About

Yu Deng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Deng has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Deng's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Yu Deng is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Yu Deng collaborates with scholars based in China. Yu Deng's co-authors include Feng He, Weina Li, Peng Zhang, Qian Chu, Xiangning Fu, Weina Li, Wei Sun, Yukun Zu, Dandan Lin and Bo Zhong and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Yu Deng

38 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronavirus disease 2019: What we know?

2020 616 citations Feng He, Yu Deng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Deng China	15	513	347	325	282	185	38	1.5k
Tao Fu China	22	603 1.2×	379 1.1×	275 0.8×	268 1.0×	300 1.6×	85	1.8k
Andrés López‐Cortés Ecuador	22	712 1.4×	640 1.8×	224 0.7×	239 0.8×	126 0.7×	104	2.0k
Anke Richters Netherlands	13	365 0.7×	253 0.7×	363 1.1×	141 0.5×	236 1.3×	36	1.5k
Chang Shu China	24	589 1.1×	231 0.7×	244 0.8×	398 1.4×	142 0.8×	73	1.8k
Luo Fang China	21	519 1.0×	436 1.3×	410 1.3×	217 0.8×	280 1.5×	83	1.7k
Shasha Hu China	15	513 1.0×	755 2.2×	119 0.4×	246 0.9×	144 0.8×	39	1.6k
Ying Yan China	22	424 0.8×	545 1.6×	275 0.8×	138 0.5×	126 0.7×	106	2.2k
Yuping Wang China	19	367 0.7×	662 1.9×	348 1.1×	168 0.6×	162 0.9×	79	1.9k
Roberta Pastorino Italy	24	322 0.6×	149 0.4×	298 0.9×	146 0.5×	237 1.3×	140	2.0k

Countries citing papers authored by Yu Deng

Since Specialization

Citations

This map shows the geographic impact of Yu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Deng more than expected).

Fields of papers citing papers by Yu Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Deng. The network helps show where Yu Deng may publish in the future.

Co-authorship network of co-authors of Yu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Deng. A scholar is included among the top collaborators of Yu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Deng. Yu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Yu, et al.. (2023). Application of Biosensors in Detecting Breast Cancer Metastasis. Sensors. 23(21). 8813–8813. 6 indexed citations

Pan, Guangtao, Ping Zhang, Aiying Chen, et al.. (2023). Aerobic glycolysis in colon cancer is repressed by naringin via the HIF1A pathway. Journal of Zhejiang University SCIENCE B. 24(3). 221–231. 10 indexed citations

Wu, Zheng, et al.. (2023). Exosomes in metastasis of colorectal cancers: Friends or foes?. World Journal of Gastrointestinal Oncology. 15(5). 731–756. 7 indexed citations

Hu, Shan, et al.. (2021). Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery. PeerJ. 9. e11923–e11923. 3 indexed citations

Li, Minjie, Ying Li, Yu Deng, et al.. (2021). Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway. Journal of Translational Medicine. 19(1). 353–353. 17 indexed citations

Hu, Shan, et al.. (2021). MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis. Journal of Translational Medicine. 19(1). 224–224. 9 indexed citations

Hu, Shan, et al.. (2020). <p>Esophageal Microenvironment: From Precursor Microenvironment to Premetastatic Niche</p>. Cancer Management and Research. Volume 12. 5857–5879. 18 indexed citations

Dong, Ming‐Hao, Feng He, & Yu Deng. (2020). How to Understand Herd Immunity in the Context of COVID-19. Viral Immunology. 34(3). 174–181. 16 indexed citations

Zhang, Man, Wei Yang, Peng Wang, et al.. (2020). CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer. Nature Communications. 11(1). 6119–6119. 155 indexed citations

10.

Lin, Dandan, Mengxin Zhang, Hao Guo, et al.. (2020). Dispensable role of CCL28 in <italic>Kras</italic>-mutated non-small cell lung cancer mouse models. Acta Biochimica et Biophysica Sinica. 52(6). 691–694. 6 indexed citations

11.

Li, Weina, Yu Deng, Qian Chu, & Peng Zhang. (2019). Gut microbiome and cancer immunotherapy. Cancer Letters. 447. 41–47. 189 indexed citations

12.

Li, Fan, et al.. (2019). Analysis of the control mechanism of lung cancer of caspase recruitment domain-containing protein 9 and myeloid-derived suppressor cell in Lewis lung cancer mice model. Saudi Journal of Biological Sciences. 26(8). 2037–2042. 4 indexed citations

13.

Wei, Ping, et al.. (2017). MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7. Biochemical and Biophysical Research Communications. 495(4). 2482–2489. 43 indexed citations

14.

Cai, Yixin, Ying Han, Ni Zhang, et al.. (2017). Modular Uniportal Video-Assisted Thoracoscopic Lobectomy and Lymphadenectomy: A Novel Pattern of Endoscopic Lung Cancer Resection. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(12). 1230–1235. 3 indexed citations

15.

Deng, Yu, et al.. (2016). MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG. Biochemical and Biophysical Research Communications. 482(4). 935–941. 38 indexed citations

16.

Hu, Fayong, Xiaonian Cao, Qinzi Xu, et al.. (2016). miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(6). 839–845. 25 indexed citations

17.

Fu, Shengling, Hongbo Tang, Yongde Liao, et al.. (2016). Expression and Clinical Significance of Insulin-Like Growth Factor 1 in Lung Cancer Tissues and Perioperative Circulation from Patients with Non-Small-Cell Lung Cancer. Current Oncology. 23(1). 12–19. 17 indexed citations

18.

Deng, Taoran, Dandan Lin, Man Zhang, et al.. (2015). Differential expression of bone morphogenetic protein 5 in human lung squamous cell carcinoma and adenocarcinoma. Acta Biochimica et Biophysica Sinica. 47(7). 557–563. 18 indexed citations

19.

Wang, Guihua, Xi Yang, Yuan Jin, et al.. (2014). TGF‐β regulates the proliferation of lung adenocarcinoma cells by inhibiting PIK3R3 expression. Molecular Carcinogenesis. 54(S1). E162–71. 11 indexed citations

20.

Wei, Ping, Chunjiao Xia, Shengling Fu, et al.. (2014). Immunohistochemistry with a novel mutation-specific monoclonal antibody as a screening tool for the EGFR L858R mutational status in primary lung adenocarcinoma. Tumor Biology. 36(2). 693–700. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact